Viewmind

ViewMind Welcomes Renata Afonso to Spearhead LATAM Expansion and Global Marketing Initiatives

ViewMind announces developer agreement with HP to help revolutionize the diagnosis and treatment of cognitive disorders ViewMind Inc., the brain health company, proudly announces the appointment of Renata Afonso as President of LATAM Operations and global Chief Marketing Officer Click to read the Press Releases Related Posts

ViewMind announces the appointment of Matthew Heller as Vice President Business Development

ViewMind sets up for the next stage of growth with executive appointment.

ViewMind today announces executive and board appointments including Danilo Verge MD, MBA as Chief Operating Officer and Chief Medical Officer and Dan D’Agostino, MBA as Director and Audit Chair.

ViewMind sets up for the next stage of growth with C-level and Director appointments.

Scarlett Chen from Verge HealthTech Fund joins ViewMind’s board of directors

ViewMind today announced Scarlett Sijia Chen, Managing Partner of Verge HealthTech Fund, has been elected to ViewMind’s board of directors. Scarlett brings decades of experience…

Our paper has been published in Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring. Mario A Parra MD PhD, Juan Granada MD, gerardo fernandez PhD, et al. (2022). In a 40-month prospective study, ViewMind showed:

Highlights: • A biomarker to ‘prospectively’ predict Alzheimer’s Disease with high accuracy. PPV 94% and NPV 100% • Ability to very accurately differentiate cognitive decline…

Memory-driven eye movements prospectively predict dementia in people at risk of Alzheimer’s disease

Oculomotor behaviors linked to cognitive performance revealed neurocognitive features of Alzheimer’s disease (AD) that can enhance the accuracy of its assessment and diagnosis

Neurocognitive disease management leader, ViewMind Inc., announces the opening of ViewMind Labs.

ViewMind is excited to announce the opening of ViewMind Labs at one of the most highly regarded centers of excellence globally for research and clinical…

ViewMind announces developer agreement with HP to help revolutionize the diagnosis and treatment of cognitive disorders

ViewMind announces developer agreement with HP to help revolutionize the diagnosis and treatment of cognitive disorders Homepage >> Press Releases >>  ViewMind announces developer agreement with HP to help revolutionize the diagnosis and treatment of cognitive disorders Click to read the Press Releases Related Posts

ViewMind Applauded by Frost & Sullivan for Its One-of-a-kind Digital Biomarker Technology for Neurocognitive Disorders

ViewMind Applauded by Frost & Sullivan for Its One-of-a-kind Digital Biomarker Technology for Neurocognitive Disorders Homepage >> Press Releases >>  ViewMind Applauded by Frost & Sullivan for Its One-of-a-kind Digital Biomarker Technology for Neurocognitive Disorders Click to read the Press Releases Related Posts

ViewMind: Most Innovative Digital Health A.I. Company – Europe & Leading Experts in Neurocognitive Digital Biomarkers

ViewMind: Most Innovative Digital Health A.I. Company – Europe & Leading Experts in Neurocognitive Digital Biomarkers Homepage >> Press Releases >>  ViewMind: Most Innovative Digital Health A.I. Company – Europe & Leading Experts in Neurocognitive Digital Biomarkers Click to read the Press Releases Related Posts